EXOME

all the information, none of the junk | biotech • healthcare • life sciences

Anthera Raises $47M

Hayward, CA-based Anthera Pharmaceuticals (NASDAQ: ANTH) said today it raised $47 million through a stock offering, after deducting expenses. The company sold about 6.7 million shares of stock at $7.50 apiece, and granted its underwriters a 30-day option to buy another 1 million shares. Citi, Leerink Swann, and Canaccord Genuity managed the offering.